J HYPERTENS 润色咨询

JOURNAL OF HYPERTENSION

出版年份：暂无数据 年文章数：3734 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：9.5% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    求经验求分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2019-04-30 tan666juan_56698866

    四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2019-04-23 ms478468928931717

    4.15投稿，4.18拒稿，没有给审稿意见。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2018-08-03 lulu9813

    送审到接收5个月，审稿时间怎么会是6个月呢？331323321_21855814 2018-07-11 发表::
    接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。    331323321_21855814 2018-07-11 23:56:00 发表:
    高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。

    331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2018-07-11 331323321_21855814

    审稿速度:6.0 | 投稿命中率:25.0
    经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-11-17 1361eea76am

    online 很慢?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-10-25 lilinlin563

    审稿速度:6.0 | 投稿命中率:50.0
    经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-10-10 念念22

    请教一个，这个杂志收费吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-10-08 sll1234

    journal of hypertension 接受以后一般多久online

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=578624, encodeId=26af5e862452, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570279, encodeId=2d6c5e0279bb, content=四月初投稿的，显示under review ，现在还没有消息，要不要发邮件问问呢？谢谢知情者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/05/20/68dedb67362e4512fb2108c6cb2d4ff0.jpg, createdBy=251a2352212, createdName=tan666juan_56698866, createdTime=Tue Apr 30 00:00:00 CST 2019, time=2019-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=850990, encodeId=b76985099065, content=4.15投稿，4.18拒稿，没有给审稿意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2a195414008, createdName=ms478468928931717, createdTime=Tue Apr 23 16:06:36 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559814, encodeId=68ae55981429, content=送审到接收5个月，审稿时间怎么会是6个月呢？<span class="quote">331323321_21855814 2018-07-11 发表::<br>接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span><span class="quote">331323321_21855814 2018-07-11 23:56:00 发表:<br>高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。</span>, beContent=331323321_21855814 2018-07-11 发表:: 接收率：约25% 审稿时间：约6个月 SCI(2016)：44 SCI(2015)：5 高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a50c21554, createdName=lulu9813, createdTime=Fri Aug 03 00:00:00 CST 2018, time=2018-08-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559113, encodeId=d0b455911381, content=审稿速度:6.0 | 投稿命中率:25.0<br>经验分享：高血压领域经典杂志，排行老二，仅次于HYPERTENSION。从送审到接受花了5个月时间，来回两次大修，一次小修，评审提的意见都很专业，不好回答，但是也中肯。跟高血压相关，实验完善的可以试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=319, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60c52400804, createdName=331323321_21855814, createdTime=Wed Jul 11 23:56:00 CST 2018, time=2018-07-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549279, encodeId=17b65492e902, content=online 很慢?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=347, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/23/24f7d57dff9e8e3597cbcfa3d9c96613.jpg, createdBy=230d2064467, createdName=1361eea76am, createdTime=Fri Nov 17 12:07:00 CST 2017, time=2017-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548561, encodeId=5d16548561ec, content=审稿速度:6.0 | 投稿命中率:50.0<br>经验分享：请问一下，接受后发的邮件问要不要open access,怎么处理？不管它还是有个页面可以选择拒绝？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=329, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/25/9015c7dc2ff7b6f9fecc2c7cffe22122.jpg, createdBy=052977944, createdName=lilinlin563, createdTime=Wed Oct 25 10:38:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548101, encodeId=fd64548101e5, content=请教一个，这个杂志收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d28c1926207, createdName=念念22, createdTime=Tue Oct 10 20:44:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548014, encodeId=794254801454, content=journal of hypertension 接受以后一般多久online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Sun Oct 08 19:52:00 CST 2017, time=2017-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538167, encodeId=c11c53816e44, content=请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？<span class="quote">daisy_226 2017-02-24 发表::<br>接收了</span>, beContent=daisy_226 2017-02-24 发表:: 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=363, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d6631671946, createdName=around, createdTime=Sun Jun 18 10:29:00 CST 2017, time=2017-06-18, status=1, ipAttribution=)]
    2017-06-18 around

    请教前辈，是不是在所有共同作者确认copyright之前杂志不会开始审稿程序？daisy_226 2017-02-24 发表::
    接收了

    daisy_226 2017-02-24 发表:: 接收了

    0

共98条页码: 3/10页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分